 Lipocine is about to report data from its clinical study on whether TLANDO can restore testosterone levels in hypogonadal men without the dose titration requirement on November 9, 2020. Low baseline testosterone levels result in a higher risk of serious complications or even death in patients with COVID-19 infection. 